Your browser doesn't support javascript.
loading
Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy.
Strosberg, Jonathan R; Al-Toubah, Taymeyah; Pellè, Eleonora; Smith, Johnna; Haider, Mintallah; Hutchinson, Tai; Fleming, Jason B; El-Haddad, Ghassan.
Afiliação
  • Strosberg JR; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida jonathan.strosberg@moffitt.org.
  • Al-Toubah T; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Pellè E; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Smith J; Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy; and.
  • Haider M; Department of Diagnostic Imaging and Interventional Radiology, Moffitt Cancer Center, Tampa, Florida.
  • Hutchinson T; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Fleming JB; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida.
  • El-Haddad G; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida.
J Nucl Med ; 62(1): 69-72, 2021 01.
Article em En | MEDLINE | ID: mdl-32444368
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Peritoneais / Receptores de Peptídeos / Obstrução Intestinal / Mesentério Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Peritoneais / Receptores de Peptídeos / Obstrução Intestinal / Mesentério Idioma: En Ano de publicação: 2021 Tipo de documento: Article